Search

everythinglearnresearchcommunity

for

Search:↓

The issue covers reproductive health topics like cancer markers, incontinence treatments, and the impact of pre-term birth.

Tofacitinib may effectively treat folliculitis decalvans.

Intralesional triamcinolone acetonide is more effective but has a higher relapse rate than platelet-rich plasma for treating alopecia areata.

TrichoFoam™ is a stable option for personalized hair loss treatment with most ingredients remaining effective for 90-180 days.

Baricitinib 4 mg is effective and safe for treating severe alopecia areata.

Oral tofacitinib helped regrow hair in over half of the patients with severe alopecia, but relapses and side effects were common.

A PTH-based treatment improved hair regrowth better than ruxolitinib in a mouse model of hair loss.

A CCS patient with severe complications was successfully treated using combined therapies.

Proactive monitoring and management are essential to maximize the benefits of Trastuzumab Deruxtecan while minimizing serious side effects.

Tofacitinib may effectively regrow hair in alopecia totalis patients.

ADSC-CE treatment safely increases hair density and thickness in androgenetic alopecia patients.

Cyproterone acetate with ethinyl estradiol is effective for treating skin symptoms related to high androgen levels, like in PCOS.

SSEA-4 can distinguish between eccrine and apocrine sweat gland ducts.

Ritlecitinib is being tested for safety and effectiveness in young children with severe alopecia areata.

A method was found to accurately measure spironolactone and canrenone in blood samples using liquid chromatography-mass spectrometry.

Cetirizine-loaded gel may effectively promote hair growth in alopecia.

Ritlecitinib effectively regrows hair in adolescents with alopecia areata and is safe.

ATP helps prevent skin damage from vandetanib by reducing stress.

Spironolactone can reduce hair growth and testosterone in hirsutism, but is less effective than combined treatments.

Triple Hormonal Blockade (ADT3) can effectively manage prostate cancer but requires careful monitoring for heart risks.

Oral tofacitinib is a promising treatment for beard hair loss in alopecia areata.

Triamcinolone is more effective than methotrexate for treating localized alopecia areata.

A new enzyme in rats may help regulate hair growth.

Using finasteride with TIP extends time off period for prostate cancer patients.

Higher sulfotransferase enzyme levels predict better response to minoxidil for hair growth.

Topical testosterone can cause acne-like skin changes.

Ritlecitinib improves hair regrowth in alopecia areata without increasing adverse risks.

Baicalin may help reduce excessive male hormone levels in PCOS.

The method accurately measures finasteride in plasma, and the test tablets are as effective as the reference ones.

Ritlecitinib effectively regrows and maintains scalp, eyebrow, and eyelash hair in alopecia areata patients.